These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32020735)

  • 1. S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501.
    Fukuda M; Funaki S; Yamazaki T; Sato S; Mukae H; Takenoyama M; Fukuoka J; Nabeshima K; Tateyama H; Ashizawa K; Hara M; Seto T; Okumura M; Sugio K
    Thorac Cancer; 2020 Mar; 11(3):693-696. PubMed ID: 32020735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1 plus cisplatin chemotherapy with concurrent radiation for thymic basaloid carcinoma.
    Tagawa T; Ohta M; Kuwata T; Awaya H; Ishida T
    J Thorac Oncol; 2010 Apr; 5(4):572-3. PubMed ID: 20357624
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study.
    Fukuda M; Yamaguchi M; Yamazaki T; Funaki S; Mukae H; Fukuoka J; Nabeshima K; Tateyama H; Ashizawa K; Tomiyama N; Hara M; Seto T; Okumura M; Sugio K
    Thorac Cancer; 2022 Sep; 13(17):2499-2506. PubMed ID: 35869676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer.
    Taira T; Yoh K; Nagase S; Kubota K; Ohmatsu H; Niho S; Onozawa M; Akimoto T; Ohe Y; Goto K
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):565-572. PubMed ID: 29387962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
    Korst RJ; Bezjak A; Blackmon S; Choi N; Fidias P; Liu G; Marx A; Wright C; Mock S; Rutledge JR; Keshavjee S
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):36-44, 46.e1. PubMed ID: 24139613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
    Nogami N; Takigawa N; Hotta K; Segawa Y; Kato Y; Kozuki T; Oze I; Kishino D; Aoe K; Ueoka H; Kuyama S; Harita S; Okada T; Hosokawa S; Inoue K; Gemba K; Shibayama T; Tabata M; Takemoto M; Kanazawa S; Tanimoto M; Kiura K
    Lung Cancer; 2015 Feb; 87(2):141-7. PubMed ID: 25534129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
    Yao L; Xu S; Xu J; Yang C; Wang J; Sun D
    Radiat Oncol; 2015 Jan; 10():10. PubMed ID: 25572571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K; Tomizawa Y; Yoshino R; Yoshii A; Matsuura M; Iwasaki Y; Koga Y; Ono A; Nishioka M; Kamide Y; Hisada T; Ishizuka T; Shirai K; Ebara T; Saitoh J; Nakano T; Sunaga N
    Lung Cancer; 2013 Dec; 82(3):449-54. PubMed ID: 24099666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203.
    Tsukita Y; Inoue A; Sugawara S; Kuyama S; Nakagawa T; Harada D; Tanaka H; Watanabe K; Mori Y; Harada T; Hino T; Fujii M; Ichinose M
    Lung Cancer; 2020 Jan; 139():89-93. PubMed ID: 31751805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study.
    Lv T; Wang Y; Ou D; Liu P; Qin S; Liu L; Lou P; Wang X
    Invest New Drugs; 2019 Apr; 37(2):352-359. PubMed ID: 30617703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.
    Li Z; Mao W; Lin N; Han S
    Clin Transl Oncol; 2016 Apr; 18(4):413-7. PubMed ID: 26304854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.
    Sasaki T; Seto T; Yamanaka T; Kunitake N; Shimizu J; Kodaira T; Nishio M; Kozuka T; Takahashi T; Harada H; Yoshimura N; Tsutsumi S; Kitajima H; Kataoka M; Ichinose Y; Nakagawa K; Nishimura Y; Yamamoto N; Nakanishi Y
    Br J Cancer; 2018 Sep; 119(6):675-682. PubMed ID: 30206369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
    Kato M; Onishi H; Matsumoto K; Tsuruta N; Higuchi K; Motoshita J; Katano M
    Anticancer Res; 2012 Nov; 32(11):5099-104. PubMed ID: 23155287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
    Ichinose Y; Seto T; Sasaki T; Yamanaka T; Okamoto I; Takeda K; Tanaka M; Katakami N; Sawa T; Kudoh S; Saka H; Nishimura Y; Nakagawa K; Fukuoka M
    J Thorac Oncol; 2011 Dec; 6(12):2069-75. PubMed ID: 22052226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.
    Wen Y; Zhao Z; Miao J; Yang Q; Gui Y; Sun M; Tian H; Jia Q; Liao D; Yang C; Du X
    Medicine (Baltimore); 2017 Dec; 96(49):e8998. PubMed ID: 29245275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-l combined with cisplatin plus concurrent chemoradiotherapy versus cisplatin plus concurrent chemoradiotherapy for Chinese patients with advanced gastric cancer: a multi-centre randomized controlled trial.
    Chen X; Li W; Sun L; Liu Y; Liu S; Ma R
    Clin Transl Oncol; 2016 Jul; 18(7):672-6. PubMed ID: 26482723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
    Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
    Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
    Kim HR; Lee CG; Choi EC; Kim JH; Koh YW; Cho BC
    Head Neck; 2016 Apr; 38 Suppl 1():E1653-9. PubMed ID: 26890965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
    Yamaguchi M; Toyokawa G; Ohba T; Sasaki T; Kometani T; Hamatake M; Hirai F; Taguchi K; Yamanaka T; Seto T; Takenoyama M; Sugio K; Ichinose Y
    Ann Thorac Surg; 2013 Nov; 96(5):1783-9. PubMed ID: 23998404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study.
    Wang X; Liu X; Li D; Wang X; Huang W; Li B
    Ann Surg Oncol; 2019 Jun; 26(6):1886-1892. PubMed ID: 30805810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.